Blood Products Advisory Committee
April 26-27, 2007
Date and Time:
The meeting will be held on April 26, 2007 from 2:00 p.m. to 6:00 p.m. and on April 27, 2007 from 8:00 a.m. to 3:30 p.m.
Location:
Hilton Hotel, Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877, 301-977-8900.
Contact Persons:
Donald W. Jehn, or Pearline K. Muckelvene, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, 1401 Rockville Pike, HFM-71, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014519516. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On April 26, 2007, the Committee will discuss issues related to implementation of blood donor screening for infection with Trypanosoma cruzi and issues related to transmissibility of Trypanosoma cruzi in donors of human cells, tissue and cellular and tissue-based products. On April 27, 2007, the Committee will hear updates on a summary of August 30-31, 2006 Meeting of the DHHS Advisory Committee on Blood Safety and Availability, a summary of the December 15, 2006 meeting of the Transmissible Spongiform Encephalopathies Advisory Committee, FDA's risk communication on plasma-derived Factor VIII and Factor XI, and summary of September 25-26, 2006 FDA Workshop on Molecular Methods in Immunohematology. The Committee will then discuss transfusion related acute lung injury (TRALI), and discuss issues related to implementation of blood donor screening for infection with West Nile Virus.
Oral Presentations:
Oral presentations from the public will be scheduled between approximately 4:30 p.m. and 5:00 p.m. on April 26, 2007 and between approximately 10:45 a.m. and 11:15 a.m. on April 27, 2007. Those desiring to make formal oral presentations should notify the contact person on or before, April 13, 2007.